HOCPF:OTC-HOYA Corporation (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 110.138

Change

+10.25 (+10.26)%

Market Cap

USD 36.78B

Volume

2.90K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-14 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
ESLOF EssilorLuxottica Société ano..

-0.08 (-0.03%)

USD 128.93B
ESLOY Essilor International SA

+0.20 (+0.14%)

USD 123.63B
HOCPY Hoya Corp

+0.99 (+0.92%)

USD 36.78B
CLPBY Coloplast A

-0.11 (-1.04%)

USD 30.06B
TRUMF Terumo Corporation

-1.94 (-9.78%)

USD 27.92B
CLPBF Coloplast A/S

N/A

USD 23.07B
SRTOY Sartorius Stedim Biotech S.A

+0.51 (+2.32%)

USD 20.63B
SDMHF Sartorius Stedim Biotech S.A

+1.75 (+0.81%)

USD 19.85B
SAUHF Straumann Holding AG

-2.00 (-1.70%)

USD 17.44B
SOAGY Sartorius Aktiengesellschaft

-0.43 (-0.89%)

USD 16.51B

ETFs Containing HOCPF

DBJP Xtrackers MSCI Japan Hedg.. 0.00 % 0.47 %

+1.80 (+1.36%)

USD 0.39B
DXJH 0.00 % 0.48 %

N/A

N/A
EWJ iShares MSCI Japan ETF 0.00 % 0.47 %

+1.29 (+1.36%)

N/A
FLJH Franklin FTSE Japan Hedge.. 0.00 % 0.09 %

+0.64 (+1.36%)

USD 0.08B
FLJP Franklin FTSE Japan ETF 0.00 % 0.09 %

+0.52 (+1.36%)

USD 1.98B
CSJP:LSE iShares VII PLC - iShares.. 0.00 % 0.00 %

+174.50 (+1.36%)

USD 0.78B
HMJD:LSE HSBC ETFs Public Limited .. 0.00 % 0.00 %

+0.55 (+1.36%)

N/A
HMJP:LSE HSBC MSCI JAPAN UCITS ETF 0.00 % 0.00 %

+30.00 (+1.36%)

N/A
IJPA:LSE iShares Core MSCI Japan I.. 0.00 % 0.00 %

+0.79 (+1.36%)

N/A
IJPD:LSE iShares Public Limited Co.. 0.00 % 0.00 %

+0.42 (+1.36%)

N/A
IJPE:LSE iShares MSCI Japan EUR He.. 0.00 % 0.00 %

+0.96 (+1.36%)

N/A
IJPN:LSE iShares MSCI Japan UCITS .. 0.00 % 0.00 %

+16.25 (+1.36%)

N/A
IJPU:LSE iShares MSCI Japan UCITS .. 0.00 % 0.00 %

+0.21 (+1.36%)

N/A
JPEH:LSE SPDR® MSCI Japan EUR Hdg.. 0.00 % 0.00 %

+0.37 (+1.36%)

USD 0.03B
JPJP:LSE SPDR® MSCI Japan UCITS E.. 0.00 % 0.00 %

+0.63 (+1.36%)

USD 106.42B
JPXG:LSE 0.00 % 0.00 %

N/A

N/A
JPXU:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

+1.75 (+1.36%)

USD 0.04B
JPXX:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

+183.00 (+1.36%)

USD 0.01B
LCJD:LSE Amundi MSCI Japan (DR) UC.. 0.00 % 0.00 %

+0.25 (+1.36%)

USD 640.06B
LCJG:LSE Lyxor Core MSCI Japan (DR.. 0.00 % 0.00 %

+0.19 (+1.36%)

USD 7.91M
LCJP:LSE Lyxor Core MSCI Japan (DR.. 0.00 % 0.00 %

+0.16 (+1.36%)

USD 640.06B
SJPA:LSE iShares Core MSCI Japan I.. 0.00 % 0.00 %

+49.00 (+1.36%)

N/A
IJPH:LSE iShares MSCI Japan GBP He.. 0.00 % 0.00 %

+1.32 (+1.36%)

N/A
UB02:LSE UBS MSCI Japan UCITS JPY .. 0.00 % 0.00 %

+45.50 (+1.36%)

N/A
UB0D:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

+18.75 (+1.36%)

N/A
UC65:LSE UBS (Lux) Fund Solutions .. 0.00 % 0.00 %

+0.71 (+1.36%)

USD 110.62B
XDNG:LSE db x-trackers JPX-Nikkei .. 0.00 % 0.00 %

+24.00 (+1.36%)

N/A
XDNS:LSE Xtrackers MSCI Japan ESG .. 0.00 % 0.00 %

+14.00 (+1.36%)

N/A
XDNU:LSE db x-trackers JPX-Nikkei .. 0.00 % 0.00 %

+0.33 (+1.36%)

N/A
XDNY:LSE Xtrackers MSCI Japan ESG .. 0.00 % 0.00 %

+0.23 (+1.36%)

N/A
XMJD:LSE Xtrackers - MSCI Japan UC.. 0.00 % 0.00 %

+1.07 (+1.36%)

N/A
XMJG:LSE 0.00 % 0.00 %

N/A

N/A
XMJP:LSE Xtrackers MSCI Japan UCIT.. 0.00 % 0.00 %

+70.50 (+1.36%)

N/A
XMUJ:LSE Xtrackers - MSCI Japan UC.. 0.00 % 0.00 %

+0.40 (+1.36%)

N/A
UB0C:LSE 0.00 % 0.00 %

N/A

N/A
CJPU:LSE iShares VII PLC - iShares.. 0.00 % 0.00 %

+2.68 (+1.36%)

USD 0.78B
SAJP:LSE iShares MSCI Japan ESG Sc.. 0.00 % 0.00 %

+0.09 (+1.36%)

USD 1.51B
SDJP:LSE iShares MSCI Japan ESG Sc.. 0.00 % 0.00 %

+0.08 (+1.36%)

USD 0.42B

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.80% 40% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.80% 37% F 34% F
Trailing 12 Months  
Capital Gain 2.06% 73% C 61% D-
Dividend Return 0.58% 25% F 5% F
Total Return 2.65% 72% C 57% F
Trailing 5 Years  
Capital Gain 15.93% 79% B- 61% D-
Dividend Return 144.94% 100% F 92% A
Total Return 160.87% 98% N/A 83% B
Average Annual (5 Year Horizon)  
Capital Gain 6.20% 63% D 51% F
Dividend Return 6.29% 59% D- 47% F
Total Return 0.08% 4% F 4% F
Risk Return Profile  
Volatility (Standard Deviation) 25.11% 86% B+ 79% B-
Risk Adjusted Return 25.03% 79% B- 64% D
Market Capitalization 36.78B 96% N/A 97% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector